Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Inpixon Prices $4.8 Million Public Offering
-
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
-
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
-
HYLETE Files Registration Statement for Proposed Initial Public Offering
-
Titan Pharma (TTNP) Prices $2.1 Million Registered Direct Offering of Common Stock, Warrants
-
Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering
-
CURE Pharmaceutical Expands Board with Two Women Directors
-
CURE Pharmaceutical Expands Board with Two Women Directors
-
BioCardia Announces Closing of $10.0 Million Public Offering
-
Maxim Group Starts Hancock Jaffe Laboratories (HJLI) at Buy
-
Kura Sushi USA Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kura Sushi USA Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Eagle Point Income Company Inc. Announces Exercise of Over-Allotment Option in Initial Public Offering
-
BioCardia, Inc. (BCDA) Prices 1.667M Unit Offering at $6/Unit; Announces Nasdaq Uplisting
-
BioCardia Announces Pricing of $10.0 Million Public Offering and Uplisting to Nasdaq
-
Coherus Biosciences (CHRS) PT Raised to $27 at Maxim Group
-
Adamis Pharmaceuticals (ADMP) Prices 12M Share Common & Warrants Offering at $1/Sh
-
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
-
Giggles N Hugs Engages Maxim Group LLC to Provide Advisory and Investment Banking Services
-
Giggles N Hugs Engages Maxim Group LLC to Provide Advisory and Investment Banking Services
-
Theralase Announces Pricing Of Prospectus Offering
-
Kura Sushi USA, Inc. (KRUS) Prices 2.9M Class A Share IPO at $14/Sh
-
Kura Sushi USA Announces Pricing of Initial Public Offering
-
Kura Sushi USA Announces Pricing of Initial Public Offering
-
TrovaGene (TROV) PT Lowered to $6 at Maxim Group
-
OncoSec Medical (ONCS) PT Lowered to $6 at Maxim Group
-
Immutep Limited (IMMP) PT Lowered to $4 at Maxim Group
-
Entera Bio (ENTX) PT Lowered to $8 at Maxim Group
-
Bionano Genomics (BNGO) PT Lowered to $7 at Maxim Group
-
TrialCard Names Joe Stallings Chief Culture & Talent Acquisition Officer
-
Fellazo Inc. Announces Closing of $50 million Initial Public Offering
-
Fellazo Inc. Announces Closing of $50 million Initial Public Offering
-
Maxim Group Starts Daxor Corp. (DXr) at Buy
-
Eagle Point Income Company Inc. Announces Closing of Initial Public Offering
-
Sterling Bancorp (STL) PT Lowered to $30 at Maxim Group
-
Fellazo Inc. (FLLC) Prices 5M Unit IPO at $10/Unit
-
Fellazo Inc. Announces Pricing of $50 Million Initial Public Offering
-
Fellazo Inc. Announces Pricing of $50 Million Initial Public Offering
-
QCR Holdings (QCRH) PT Raised to $40 at Maxim Group
-
Universal Electronics, Inc. (EIC) Prices 1.2M Share IPO at $19.89/Sh
-
Eagle Point Income Company Inc. Prices Initial Public Offering
-
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
-
PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables
-
Maxim Group Downgrades Viveve Medical (VIVE) to Hold
-
Seanergy Maritime (SHIP) PT Lowered to $1 at Maxim Group
-
Co-Diagnostics Mosquito Testing Products Generate Buzz
-
Co-Diagnostics Mosquito Testing Products Generate Buzz
-
Hemispherx Biopharma (HEB) Active After New $70M Equity Distribution Agreement
-
Maxim Group Downgrades Intec Pharma Ltd. (NTEC) to Hold
-
Xenetic Biosciences, Inc. Closes $15.0 Million Underwritten Public Offering and Completes Acquisition of Innovative CAR T Technology Platform

